ESMO Expert Consensus Statements on the management of breast cancer during pregnancy (PrBC)

• Published in: Annals of oncology Vol. 34; no. 10; pp. 849 - 866
• Main Authors: Loibl, S., Azim, H.A., Bachelot, T., Berveiller, P., Bosch, A., Cardonick, E., Denkert, C., Halaska, M.J., Hoeltzenbein, M., Johansson, A.L.V., Maggen, C., Markert, U.R., Peccatori, F., Poortmans, P., Saloustros, E., Saura, C., Schmid, P., Stamatakis, E., van den Heuvel-Eibrink, M., van Gerwen, M., Vandecaveye, V., Pentheroudakis, G., Curigliano, G., Amant, F.
• Format: Journal Article
• Language: English
• Published: England Elsevier Ltd 01.10.2023
• Subjects: (neo) adjuvant therapy; Cancer and Oncology; Cancer och onkologi; Clinical Medicine; Klinisk medicin; Medical and Health Sciences; Medicin och hälsovetenskap; pregnancy management during cancer; pregnancy-related breast cancer; (neo) adjuvant therapy; pregnancy management during cancer; pregnancy-related breast cancer

The management of breast cancer during pregnancy (PrBC) is a relatively rare indication and an area where no or little evidence is available since randomized controlled trials cannot be conducted. In general, advances related to breast cancer (BC) treatment outside pregnancy cannot always be transla...